MAGE-A3 peptides presented by HLA class II molecules

Details for Australian Patent Application No. 2002339748 (hide)

Owner LUDWIG INSTITUTE FOR CANCER RESEARCH

Inventors Chaux, Pascal; Zhang, Yi; Boon-Falleur, Thierry; Van Der Bruggen, Pierre

Agent Davies Collison Cave

Pub. Number AU-A-2002339748

PCT Number PCT/US02/15475

PCT Pub. Number WO2002/095051

Priority 09/860,840 18.05.01 US

Filing date 16 May 2002

Wipo publication date 3 December 2002

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 09/860,840 18.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002339748

8 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002339749-OSCILLATING-TYPE GENERATOR

2002339747-SKIN PREPARATION COMPRISING A TOCOPHEROL DERIVATIVE FOR EXTERNAL APPLICATION